Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Locatelli

Showing results (71-80 of 915) with videos related to

Pageof 92
Sort By:
Annals of Hematology|August 29, 2020
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapiesAndreas Viardot, Franco Locatelli, Julia Stieglmaier, et al.
Expert Opinion on Pharmacotherapy|September 15, 2015
Eltrombopag for treatment of thrombocytopenia-associated disordersPietro Merli, Luisa Strocchio, Luciana Vinti, et al.
HLA|February 21, 2019
Identification of the novel HLA-A*01:289 allele in an Italian patientTiziana Galluccio, Franco Locatelli, Maria Troiano, et al.
Trends in Molecular Medicine|November 15, 2017
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a PerspectiveLoredana Cifaldi, Franco Locatelli, Emiliano Marasco, et al.
American Journal of Hematology|August 29, 2006
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantationAlessandro Busca, Franco Locatelli, Filippo Marmont, et al.
Current Drug Targets|February 4, 2012
The Yin and Yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunityPerla Filippini, Alfredo Cesario, Massimo Fini, et al.
BMC Medicine|May 26, 2011
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implicationsRoberta Ciarapica, Lucio Miele, Antonio Giordano, et al.
HLA|September 19, 2018
The novel HLA-DRB3*02:02:11 allele identified in an Italian individualMariarosa Battarra, Franco Locatelli, Tiziana Galluccio, et al.
American Journal of Hematology|December 15, 2023
Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editingSelim Corbacioglu, Haydar Frangoul, Franco Locatelli, et al.
HLA|May 29, 2020
Characterization of the novel HLA-DQA1*01:49 allele by sequencing-based typingMarine Cargou, Marco Andreani, Franco Locatelli, et al.
Pageof 92

Showing results (71-80 of 915) with videos related to

Sort By:
Pageof 92
Annals of Hematology|August 29, 2020
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapiesAndreas Viardot, Franco Locatelli, Julia Stieglmaier, et al.
Expert Opinion on Pharmacotherapy|September 15, 2015
Eltrombopag for treatment of thrombocytopenia-associated disordersPietro Merli, Luisa Strocchio, Luciana Vinti, et al.
HLA|February 21, 2019
Identification of the novel HLA-A*01:289 allele in an Italian patientTiziana Galluccio, Franco Locatelli, Maria Troiano, et al.
Trends in Molecular Medicine|November 15, 2017
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a PerspectiveLoredana Cifaldi, Franco Locatelli, Emiliano Marasco, et al.
American Journal of Hematology|August 29, 2006
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantationAlessandro Busca, Franco Locatelli, Filippo Marmont, et al.
Current Drug Targets|February 4, 2012
The Yin and Yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunityPerla Filippini, Alfredo Cesario, Massimo Fini, et al.
BMC Medicine|May 26, 2011
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implicationsRoberta Ciarapica, Lucio Miele, Antonio Giordano, et al.
HLA|September 19, 2018
The novel HLA-DRB3*02:02:11 allele identified in an Italian individualMariarosa Battarra, Franco Locatelli, Tiziana Galluccio, et al.
American Journal of Hematology|December 15, 2023
Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editingSelim Corbacioglu, Haydar Frangoul, Franco Locatelli, et al.
HLA|May 29, 2020
Characterization of the novel HLA-DQA1*01:49 allele by sequencing-based typingMarine Cargou, Marco Andreani, Franco Locatelli, et al.
Pageof 92